中國武夷(000797.SZ):完成出售獲能公司100%股權
格隆匯6月13日丨中國武夷(000797.SZ)公佈,公司通過公開轉讓武夷企業有限公司(以下簡稱"武夷企業"或"賣方")持有的獲能有限公司(以下簡稱"獲能公司")100%股權的方式出售福州武夷中心房產,由添宜發展有限公司(以下簡稱"添宜公司"或"買方")中標,交易價格為130,903,731港元(含股權和債務,摺合人民幣106,564,800元)。
截至目前,賣方已按協議約定解除房產抵押並收到買方支付的餘款,獲能公司所欠武夷企業借款已清償。交易雙方已按協議約定履行完畢全部內容,此次交易完成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.